Exelixis Announces Zanzalintinib in Combination with an Immune Checkpoint Inhibitor Improved Overall Survival in STELLAR-303 Phase 3 Pivotal Trial in Patients with Metastatic Colorectal Cancer

1 month ago 6
Read Entire Article
  1. Homepage
  2. Finance
  3. Exelixis Announces Zanzalintinib in Combination with an Immune Checkpoint Inhibitor Improved Overall Survival in STELLAR-303 Phase 3 Pivotal Trial in Patients with Metastatic Colorectal Cancer

Related

USAID failed to monitor uses of Musk's Starlink terminals sent to Ukraine, says watchdog

USAID failed to monitor uses of Musk's Starlink terminals se...

56 minutes ago 0
’Big Short’ investor Burry turned more bullish on second quarter

’Big Short’ investor Burry turned more bullish on second qua...

56 minutes ago 0
Form 13G CIDARA THERAPEUTICS For: 14 August

Form 13G CIDARA THERAPEUTICS For: 14 August

56 minutes ago 0

Trending

1. epic games
2. lainey wilson
3. the kingdom chiefs
4. botafogo
5. deportivo pereira - américa
6. ronda rousey
7. one last ride tour 2026
8. michael king
9. gianni paolo
10. beyond meat

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

6 months ago 450
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

7 months ago 221
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

5 months ago 191
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

5 months ago 162
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

4 months ago 150
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved